Positive Efficacy of Lactiplantibacillus plantarum MH-301 as A Postoperative Adjunct to Endoscopic Sclerotherapy for Internal Hemorrhoids: A Randomized, Double-blind, Placebo-controlled Trial

Kaige Zhang,Hui Liu,Peng Liu,Qi Feng,Lihong Gan,Ling Yao,Gen Huang,Ziling Fang,Tingtao Chen,Nian Fang

DOI: https://doi.org/10.1039/d3fo02936k

2023-08-20

Abstract:Background: Endoscopic sclerotherapy is a widely used minimally invasive procedure for internal hemorrhoids, yet postoperative symptoms remain a concern. The purpose of this study is to investigate the postoperative adjuvant efficacy of Lactiplantibacillus plantarum. Method: In this study, patients (≥18 years) with internal hemorrhoids that conformed to Golighter's classification of grade I-III received administration of L. plantarum MH-301 for 4 weeks following endoscopic sclerotherapy. The primary clinical endpoint in this study was the improvement rate, which was defined as the percentage of patients whose n-HDSS score decreased to 0 following the procedure. Stools were collected for high-throughput sequencing analysis postoperatively. Result: A total of 103 participants (51 in the LP group and 52 in the C group) were recruited, with 96 complete the entire trial (49 in the LP group and 47 in the C group). The primary clinical endpoint showed a higher improvement rate in the LP group (87.8% vs 70.2%, P=0.045). High-throughput sequencing analysis demonstrated that the LP group had a greater diversity of intestinal microbiota and a higher relative abundance of beneficial bacteria such as Bifidobacterium, Megamonas, and Lactobacillus. No significant difference in postoperative complications and adverse events. Conclusion: This paper concludes that the administration of L. plantarum MH-301 after endoscopic sclerotherapy can further increase the efficacy of the procedure and improve bowel movements. Regulation of intestinal microbiota may be the potential mechanism for the efficacy of L. plantarum MH-301.

biochemistry & molecular biology,food science & technology